You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

KRAS/BRAF Wild-type

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer Trial in Guangzhou (Cetuximab, Capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Mar 7, 2023

Colorectal Cancer, KRAS Wildtype, NRAS Wildtype Trial in Toronto (Trametinib, Panitumumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Colon Cancer Trial in United States (Panitumumab, Nivolumab, Ipilimumab)

Active, not recruiting
Has Results
  • Colon Cancer
  • Tampa, Florida
  • +4 more
Nov 10, 2021

Metastatic Colorectal Cancer Trial in Beijing (CPGJ602, cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Aug 16, 2021

Metastatic Colorectal Cancer Trial in Worldwide (Futuximab/modotuximab, Trifluridine/Tipiracil)

Recruiting
  • Metastatic Colorectal Cancer
  • Ann Arbor, Michigan
  • +10 more
Dec 2, 2022

Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer Trial (Cetuximab combind mFOLFOX6/FOLFIRI)

Completed
  • Wild-type KRAS,NRAS and BRAF V600E Metastatic Colorectal Cancer
  • Cetuximab combind mFOLFOX6/FOLFIRI
  • (no location specified)
Jan 17, 2021

Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)

Recruiting
  • Cancer of the Colon
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022

Colorectal Cancer Trial in United States (Cetuximab, Neratinib)

Withdrawn
  • Colorectal Cancer
  • Gainesville, Florida
  • +11 more
Oct 26, 2021

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Anaheim, California
  • +47 more
Mar 28, 2022

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Colorectal Cancer, Liver Metastases Trial in Shanghai (mFOLFOX6 + Cetuximab, mFOLFOX 6)

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • mFOLFOX6 + Cetuximab
  • mFOLFOX 6
  • Shanghai, China
    Zhongshan hosptial, Fudan University
Jul 14, 2023

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,

Completed
  • Colorectal Cancer
  • +12 more
  • Anlotinib Hydrochloride
  • +2 more
  • Hangzhou, Zhejiang, China
  • +1 more
Jul 12, 2022

Metastatic Colorectal Cancer Trial in Beijing (fruquintinib plus capecitabine)

Recruiting
  • Metastatic Colorectal Cancer
  • fruquintinib plus capecitabine
  • Beijing, China
    National Center/Cancer Hospital, China Academy of Medical Scienc
Aug 17, 2022

Metastatic Colorectal Cancer Trial in Beijing, Tianjin (CMAB009, Irinotecan, Folinic acid)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +1 more
Oct 18, 2022

Disease or R Group Histiocytoses Trial in Paris (Cobimetinib, Placebo oral tablet)

Active, not recruiting
  • Disease or R Group Histiocytoses
  • Paris, France
    Service de Médecine interne - La Pitié Salpêtrière
Mar 21, 2022

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Solid Tumor, KRAS Mutation Trial (BI 3706674)

Not yet recruiting
  • Solid Tumor, KRAS Mutation
  • BI 3706674
  • (no location specified)
Sep 29, 2023

Metastatic Colorectal Cancer Trial in Denmark, Norway, Sweden (Cetuximab, Irinotecan, Oxaliplatin)

Completed
  • Metastatic Colorectal Cancer
  • Aalborg, Denmark
  • +11 more
Oct 29, 2020

Colo-rectal Cancer, Capecitabine, Cetuximab Trial in Chengdu (mCapOX plus cetuximab, mFOLFOX6 plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • +2 more
  • mCapOX plus cetuximab
  • mFOLFOX6 plus cetuximab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Sep 1, 2021

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

Colorectal Cancer Trial in Saint-herblain (Oxaliplatin, Folinic Acid, 5-fluoro-uracil)

Completed
  • Colorectal Cancer
  • Saint-herblain, France
    Centre rené Gauducheau
Jan 7, 2022

Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation Trial in Italy (Bevacizumab, Cetuximab, 5-FU)

Recruiting
  • Colorectal Cancer
  • +2 more
  • Coppito, L'Aquila, Italy
  • +3 more
Sep 10, 2021

Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

Recruiting
  • Colorectal Cancer
  • Pisa, PI, Italy
    U.O. Oncologia 2 Universitaria
Aug 3, 2022